ReviewRSC advances2025

Thiazole-driven heterocyclic hybrids as EGFR inhibitors: progress in synthesis and anticancer applications.

Ancilla Dsouza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.